On ECHEMI
Home > Drugs > Myocardial infarction
Myocardial infarction
Myocardial infarction, also known as myocardial infarction, refers to a sharp reduction or interruption of coronary blood supply on the basis of coronary artery lesions, causing severe and persistent acute ischemic necrosis of the corresponding myocardium. The clinical manifestations are sudden, severe and persistent pain behind the sternum, characteristic dynamic changes in electrocardiograms and increased serum enzymes. Complications such as arrhythmia, heart failure, and shock may occur, which can often be life-threatening. The symptoms of myocardial infarction in most people are chest pain and chest tightness. The causes are generally excessive fatigue, emotional excitement, overeating, shock after major surgery or massive hemorrhage, etc. In terms of age, middle-aged men between the ages of 45 and 60 are at high risk of myocardial infarction.
Related Drugs
Warfarin Sodium Tablets
Indication: Suitable for patients who need long-term continuous anticoagulation: ① It can prevent the formation and development of blood clots and is used to treat thromboembolic diseases; ② It can treat venous thrombosis after surgery or trauma, and can be used as an auxiliary medication for myocardial infarction; ③ It can be used as a preventive medication for patients who have had thromboembolic diseases and those who are at risk of postoperative thrombotic complications.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Warfarin Sodium Tablets
Indication: Suitable for patients who need long-term continuous anticoagulation: ① It can prevent the formation and development of blood clots and is used to treat thromboembolic diseases; ② It can treat venous thrombosis after surgery or trauma, and can be used as an auxiliary medication for myocardial infarction; ③ It can be used as a preventive medication for patients who have had thromboembolic diseases and those who are at risk of postoperative thrombotic complications.
Manufacturer:

Beijing Jialin Pharmaceutical Co., Ltd.

Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

Yabao Pharmaceutical Group Co., Ltd.

Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

Sichuan Defeng Pharmaceutical Co., Ltd.

Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

Hebei TIANCHENG Pharmaceutical Co., Ltd.

Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

Xi'an Fenghua Pharmaceutical Co., Ltd.

Gadopentetate Diglucamide Injection
Indication: MRI enhancement of the central nervous system and other parts. For normal brain tissue, there is no enhancement due to the presence of the blood-brain barrier; but the dura mater, choroid plexus, and pituitary gland may be enhanced. In addition to the central nervous system, other parts can also be applied. It can significantly increase the signal intensity of liver cancer and hepatic vascular cysts; distinguish liver cysts from normal liver tissue; diagnose or differentiate acute, subacute and chronic myocardial infarction, congenital heart disease, and dissecting aneurysms; it is also helpful for the diagnosis of nasopharyngeal carcinoma, breast cancer, and kidney tumors.
Manufacturer:

Beijing Beilu Pharmaceutical Co., Ltd.

Gadopentetate Diglucamide Injection
Indication: MRI enhancement of the central nervous system and other parts. For normal brain tissue, there is no enhancement due to the presence of the blood-brain barrier; but the dura mater, choroid plexus, and pituitary gland may be enhanced. In addition to the central nervous system, other parts can also be applied. It can significantly increase the signal intensity of liver cancer and hepatic vascular cysts; distinguish liver cysts from normal liver tissue; diagnose or differentiate acute, subacute and chronic myocardial infarction, congenital heart disease, and dissecting aneurysms; it is also helpful for the diagnosis of nasopharyngeal carcinoma, breast cancer, and kidney tumors.
Manufacturer:

Beijing Beilu Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.